Aldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activity

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Gangavarapu, Kalyan J ^a   Azabdaftari, Gissou ^a   Morrison, Carl D ^a   Miller, Austin ^a   Foster, Barbara A ^a   Huss, Wendy J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDH1A1 PROTEIN; ANDROGEN RECEPTOR; BREAST CANCER RESISTANCE PROTEIN; CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE STEM CELL; PROTEIN FUNCTION; RAT; STEM CELL; UROGENITAL SINUS;

RATTUS;

ALDEHYDE DEHYDROGENASE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CELL SEPARATION; CHROMOGRANIN A; FLUORESCENT DYES; HUMANS; KIDNEY; MALE; MESODERM; MICE; MICE, SCID; NEOPLASM PROTEINS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; RATS; RECEPTORS, ANDROGEN; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84886220318     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt343     Document Type: Article

References (40)

1. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC, J Exp Med 1996 183 1797 1806 10.1084/jem.183.4.1797 8666936 (Pubitemid 26134320)
2. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM, Smith C, Proc Natl Acad Sci USA 1999 96 9118 9123 10.1073/pnas.96.16.9118 10430905 (Pubitemid 29374717)
3. ABC transporters, drug resistance, and cancer stem cells. Dean M, J Mammary Gland Biol Neoplasia 2009 14 3 9 10.1007/s10911-009-9109-9 19224345
4. Aldehyde dehydrogenase as a marker for stem cells. Moreb JS, Curr Stem Cell Res Ther 2008 3 237 246 10.2174/157488808786734006 19075754
5. Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity. Muramoto GG, Russell JL, Safi R, Salter AB, Himburg HA, Daher P, Meadows SK, Doan P, Storms RW, Chao NJ, McDonnell DP, Chute JP, Stem Cells 2010 28 523 534 20054864
6. ALDH1 as a functional marker of cancer stem and progenitor cells. Douville J, Beaulieu R, Balicki D, Stem Cells Dev 2009 18 17 25 10.1089/scd.2008.0055 18573038
7. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. Sladek NE, J Biochem Mol Toxicol 2003 17 7 23 10.1002/jbt.10057 12616643 (Pubitemid 36416554)
8. High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzman-Ramirez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini MG, Pelger RC, van der Pluijm G, Cancer Res 2010 70 5163 5173 10.1158/0008-5472.CAN-09-3806 20516116
9. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N, Comi GP, Stem Cells 2006 24 975 985 10.1634/stemcells.2005-0217 16293577 (Pubitemid 44464730)
10. ALDH1 expression correlates with favorable prognosis in ovarian cancers. Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X, Liu J, Mod Pathol 2009 22 817 823 19329942
11. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G, Cell Stem Cell 2007 1 555 567 10.1016/j.stem.2007.08.014 18371393 (Pubitemid 350056407)
12. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM, Cancer Res 2009 69 3382 3389 10.1158/0008-5472.CAN-08-4418 19336570
13. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL, Mol Cancer Res 2009 7 330 338 10.1158/1541-7786.MCR-08- 0393 19276181
14. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, Hidalgo M, Maitra A, Matsui W, J Natl Cancer Inst 2010 102 340 351 10.1093/jnci/djp535 20164446
15. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F, Cancer Epidemiol Biomarkers Prev 2010 19 327 337 10.1158/1055-9965.EPI-09-0865 20142235
16. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, Wu J, Exp Mol Pathol 2010 89 27 35 10.1016/j.yexmp.2010.05.005 20511115
17. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, Moscatelli D, Wilson EL, Stem Cells 2009 27 2220 2228 10.1002/stem.135 19544409
18. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F, Lab Invest 2010 90 234 244 10.1038/labinvest.2009.127 20010854
19. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. Croker AK, Goodale D, Chu J, Postenka C, Hedley BD, Hess DA, Allan AL, J Cell Mol Med 2008 13 2236 2252 18681906
20. ALDH1-bright epithelial ovarian cancer cells are associated with cd44 expression, drug resistance, and poor clinical outcome. Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC, Am J Pathol 2012 180 1159 1169 10.1016/j.ajpath.2011.11.015 22222226
21. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44(+) human breast cancer cells. Croker AK, Allan AL, Breast Cancer Res Treat 2011 133 75 87 21818590
22. ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate. Mathew G, Timm EA Jr, Sotomayor P, Godoy A, Montecinos VP, Smith GJ, Huss WJ, Cell Cycle 2009 8 1053 1061 10.4161/cc.8.7.8043 19270533
23. Central quadrant procurement of radical prostatectomy specimens. Morrison C, Cheney R, Johnson CS, Smith G, Mohler JL, Prostate 2009 69 770 773 10.1002/pros.20925 19204997
24. Isolation and applications of prostate side population cells based on dye cycle violet efflux. Gangavarpu KJ, Huss WJ, Curr Protoc Toxicol 2011 Chapter 22 nit 22 22
25. Side population analysis using a violet-excited cell-permeable DNA binding dye. Telford WG, Bradford J, Godfrey W, Robey RW, Bates SE, Stem cells 2007 25 1029 1036 10.1634/stemcells.2006-0567 17185610 (Pubitemid 46572601)
26. Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, Huss WJ, PLoS One 2013 8 55062 10.1371/journal.pone.0055062 23383057
27. Foster BA, Donjacour AA, Techniques for Modeling Human Cancer in Mice: a Practical Guide for Dissections, Microsurgery and Other Biomethods. DVD compilation of techniques from "Techniques for Modeling Human Cancer in Mice": workshop held at Jackson Laboratory Mouse Models of Human Cancers Consortium, NCI: Bar Harbor, Maine 2002
28. Mouse urogenital development: a practical approach. Staack A, Donjacour AA, Brody J, Cunha GR, Carroll P, Differentiation 2003 71 402 413 10.1046/j.1432-0436.2003.7107004.x 12969333 (Pubitemid 37249226)
29. Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to multispecies recombinant urogenital sinus xenografts. Vander Griend DJ, Konishi Y, De Marzo AM, Isaacs JT, Meeker AK, Prostate 2009 69 1557 1564 10.1002/pros.21001 19562732
30. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stassi G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS, Clin Cancer Res 2010 16 45 55 10.1158/1078-0432.CCR-09-1630 20028757
31. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS, Cancer Res 2009 69 1302 1313 10.1158/0008-5472.CAN-08- 2741 19190339
32. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34 + CD38- stem/progenitor cell compartment. Pierre-Louis O, Clay D, Brunet De La Grange P, Blazsek I, Desterke C, Guerton B, Blondeau C, Malfuson JV, Prat M, Bennaceur-Griscelli A, Lataillade JJ, Le Bousse-Kerdiles MC, Stem Cells 2009 27 2552 2562 10.1002/stem.186 19650038
33. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS, Genes Dev 2003 17 1253 1270 10.1101/gad.1061803 12756227 (Pubitemid 36583168)
34. Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON, Prostate 2010 70 491 501 19938015
35. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ, Cancer Res 2005 65 6640 6650 10.1158/0008-5472.CAN-04-2548 16061644 (Pubitemid 41060700)
36. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, Dahiya R, Cunha GR, Differentiation 1998 63 131 140 10.1046/j.1432-0436.1998.6330131.x 9697307 (Pubitemid 28362377)
37. Brief report: a bioassay to identify primary human prostate cancer repopulating cells. Toivanen R, Berman DM, Wang H, Pedersen J, Frydenberg M, Meeker AK, Ellem SJ, Risbridger GP, Taylor RA, Stem Cells 2011 29 1310 1314 10.1002/stem.668 21674698
38. Effects of mesenchyme of the embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study. Wong YC, Cunha GR, Hayashi N, Acta Anat 1992 143 139 150 10.1159/000147240 1598820
39. Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma. Hayashi N, Cunha GR, Wong YC, Cancer Res 1990 50 4747 4754 2369750 (Pubitemid 20230424)
40. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma. Hayashi N, Cunha GR, Cancer Res 1991 51 4924 4930 1893381